Asthma translational medicine: Report card

Biochemical Pharmacology

Volumn 82, Issue 6, 2011, Pages 567-585

  Mullane, Kevin ^a  

^a Profectus Pharma Consulting   (United States)

Author keywords

Animal models; Asthma therapeutics; Chemokines; Cytokines; Eosinophils; T helper 2 cells

Indexed keywords

AIR 654; ALTRAKINCEPT; AMG 317; ANRUKINZUMAB; ANTIASTHMATIC AGENT; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN INHIBITOR; ASM 8; BIMOSIAMOSE; CYTOKINE; DACLIZUMAB; EFALIZUMAB; ENOKIZUMAB; ETANERCEPT; GOLIMUMAB; GSK 679586; ILOPROST; IMA 026; IMA 628; IMMUNOGLOBULIN E; INFLIXIMAB; LEBRIKIZUMAB; LY 239111; MEPOLIZUMAB; PASCOLIZUMAB; PHOSPHODIESTERASE IV INHIBITOR; PITRAKINRA; PROSTAGLANDIN D2 ANTAGONIST; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RESLIZUMAB; TRALOKINUMAB; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; BRONCHITIS; BRONCHOSPASM; BRONCHUS MUSCLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL LINEAGE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE ASSOCIATION; EOSINOPHIL; EOSINOPHILIC BRONCHITIS; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOSURVEILLANCE; INNATE IMMUNITY; LUNG TUBERCULOSIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MEDIATOR RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; SJOEGREN SYNDROME; TH2 CELL; TRANSLATIONAL RESEARCH;

EID: 80051548418     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.06.038     Document Type: Note

References (201)

1. D.R. Taylor, E.D. Bateman, L.-P. Boulet, H.A. Boushey, W.W. Busse, and T.B. Casale A new perspective on concepts of asthma severity and control Eur Respir J 32 2008 545 554
2. K. Mullane The increasing challenge of discovering asthma drugs Biochem Pharmacol 2011 10.1016/j.bcp.2011.06.033
3. Asthma. Nat Biotechnol 2000;18 Suppl:IT10-1.
4. J.-C. Renauld New insights into the role of cytokines in asthma J Clin Pathol 54 2001 577 589 (Pubitemid 32756438)
5. S.H. Gavett, X. Chen, F. Finkelman, and M. Wills-Karp Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia Am J Respir Cell Mol Biol 10 1994 587 593
6. C.G. Garlisi, A. Falcone, T.T. Kung, D. Stelts, K.J. Pennline, and A.J. Beavis T cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice Clin Immunol Immunopathol 75 1995 75 83
7. M. Wills-Karp, and S.L. Ewart The genetics of allergen-induced airway hyperresponsiveness in mice Am J Respir Crit Care Med 156 1997 S89 S96
8. D.A. Randolph, C.J. Carruthers, S.J. Szabo, K.M. Murphy, and D.D. Chaplin Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma J Immunol 162 1999 2375 2383 (Pubitemid 29288865)
9. X.M. Li, B.H. Schofield, Q.F. Wang, K.H. Kim, and S.K. Huang Induction of pulmonary allergic responses by antigen-specific Th2 cells J Immunol 160 1998 1378 1384 (Pubitemid 28093438)
10. L.S. Van Rijt, S. Jung, A. Kleinjan, N. Vos, M. Willart, and C. Duez In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma J Exp Med 201 2005 981 991 (Pubitemid 40524467)
11. T. Koya, H. Matsuda, S. Matsubara, N. Miyahara, A. Dakhama, and K. Takeda Differential effects of dendritic cell transfer in airway hyperresponsiveness and inflammation Am J Respir Cell Mol Biol 41 2009 271 280
12. G.R. Zosky, A.N. Larcombe, O.J. White, J.T. Burchell, C. von Garnier, and P.G. Holt Airway hyperresponsiveness is associated with activated CD4+ T cells in the airways Am J Physiol Lung Cell Mol Physiol 297 2009 L373 L379
13. T. Ohtomo, O. Kaminuma, J. Yamada, N. Kitamura, A. Abe, and N. Kobayashi Eosinophils are required for the induction of bronchial hyperresponsiveness in a Th transfer model of BALB/c background Int Arch Allergy Immunol 152 Suppl. 1 2010 79 82
14. S.P. Chapoval, E.V. Marietta, M.K. Smart, and C.S. David Requirements for allergen-induced airway inflammation and hyperreactivity in CD4-deficient and CD4-sufficient HLA-DQ transgenic mice J Allergy Clin Immunol 108 2001 764 771 (Pubitemid 33096208)
15. J.J. Lee, D. Dimina, M.P. Macias, S.I. Ochkur, M.P. McGarry, and K.R. O'Neill Defining a link with asthma in mice congenitally deficient in eosinophils Science 305 2004 1773 1776 (Pubitemid 39249644)
16. J. Elias The relationship between asthma and COPD. Lessons from transgenic mice Chest 126 2 Suppl. 2004 159S 161S
17. S. Finotto, M.F. Neurath, J.N. Glickman, S. Qin, H.A. Lehr, and F.H.Y. Green Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet Science 295 2002 336 338 (Pubitemid 34074365)
18. P.J. Barnes The cytokine network in asthma and chronic obstructive pulmonary disease J Clin Invest 118 2008 3546 3556
19. F.D. Finkelman, S.P. Hogan, G.K. Hershey, M.E. Rothenberg, and M. Wills-Karp Importance of cytokines in murine allergic airway disease and human asthma J Immunol 184 2010 1663 1674
20. C. Palmqvist, A.J. Wardlaw, and P. Bradding Chemokines and their receptors as potential targets for the treatment of asthma Br J Pharmacol 151 2007 725 736 (Pubitemid 47075313)
21. C.M. Lloyd, and E.M. Hessel Functions of T cells in asthma: more than just Th2 cells Nat Rev Immunol 10 2010 838 848
22. S.T. Holgate, G. Roberts, H.S. Arshad, P.H. Howarth, and D.E. Davies The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis Proc Am Thorac Soc 6 2009 655 659
23. C.M. Lloyd, and C.M. Hawrylowicz Regulatory T cells in asthma Immunity 31 2009 438 449
24. B.D. Medoff, S.Y. Thomas, and A.D. Luster T cell trafficking in allergic asthma: the ins and outs Annu Rev Immunol 26 2008 205 232 (Pubitemid 351600375)
25. T. Kodama, T. Matsuyama, K. Kuribayashi, Y. Nishioka, M. Sugita, and S. Akira IL-18 deficiency selectively enhances allergen-induced eosinophilia in mice J Allergy Clin Immunol 105 2000 45 53 (Pubitemid 30059101)
26. S. Yamagata, K. Tomita, R. Sato, A. Niwa, H. Higashino, and Y. Tohda Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model Clin Exp Immunol 154 2008 295 304
27. C. Hartwig, T. Tschernig, M. Mazzega, A. Braun, and D. Neumann Endogenous IL-18 in experimentally induced asthma affects cytokine serum levels but is irrelevant for clinical symptoms Cytokine 42 2008 298 305
28. B. Zhou, M.R. Comeau, T. De Smedt, H.D. Liggitt, M.E. Dahl, and D.B. Lewis Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice Nat Immunol 6 2005 1047 1053 (Pubitemid 41486190)
29. M.B. Headley, B. Zhou, W.X. Shih, T. Aye, M.R. Comeau, and S.F. Ziegler TSLP conditions the lung immune environment for the generation of pathogenic innate and antigen-specific adaptive immune responses J Immunol 182 2009 1641 1647
30. A. Al-Shami, R. Spolski, J. Kelly, A. Keane-Myers, and W.J. Leonard A role for TSLP in the development of inflammation in an asthma model J Exp Med 202 2005 829 839 (Pubitemid 41345971)
31. S. Ying, B. O'Connor, J. Ratoff, Q. Meng, K. Mallett, and D. Cousins Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity J Immunol 174 2005 8183 8190 (Pubitemid 40806330)
32. V. Lombardi, A.K. Singh, and O. Akbari The role of costimulatory molecules in allergic disease and asthma Int Arch Allergy Immunol 151 2010 179 189
33. K. Chattopadhyay, E. Lazar-Molnar, Q. Yan, R. Rubinstein, C. Zhan, and V. Vigdorovich Sequence, structure, function, immunity: structural genomics of costimulation Immunol Rev 229 2009 356 386
34. P. Sakthivel Bench to bedside of CTLA-4: a novel immuno-therapeutic agent for inflammatory disorders Recent Pat Inflamm Allergy Drug Discov 3 2009 84 95
35. A.M. Keane-Myers, W.C. Gause, F.D. Finkelman, X.D. Xhou, and M. Wills-Karp Development of murine allergic asthma is dependent upon B7-2 costimulation J Immunol 160 1998 1036 1043 (Pubitemid 28049351)
36. B. Linhart, S. Bigenzahn, A. Hartl, C. Lupinek, J. Thalhamer, and R. Valenta Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy J Immunol 178 2007 3924 3931 (Pubitemid 46417663)
37. Y. Ohshima, L.P. Yang, T. Uchiyama, Y. Tanaka, P. Baum, and M. Sergerie OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors Blood 92 1998 3338 3345 (Pubitemid 28492342)
38. A. Hoshino, Y. Tanaka, H. Akiba, Y. Asakura, Y. Mita, and T. Sakurai Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma Eur J Immunol 33 2003 861 869 (Pubitemid 36546673)
39. E.J. Scheinman, and O. Avni Transcriptional regulation of GATA3 in T helper cells by the integrated activities of transcription factors downstream of the interleukin-4 receptor and T cell receptor J Biol Chem 284 2009 3037 3048
40. K. Maneechotesuwan, Y. Xin, K. Ito, E. Jazrawi, K.Y. Lee, and O.S. Usmani Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3 J Immunol 178 2007 2491 2498 (Pubitemid 46233450)
41. J.L. Grogan, and R.M. Locksley T helper cell differentiation: on again, off again Curr Opin Immunol 14 2002 366 372 (Pubitemid 34327980)
42. Y. Nakamura, and M. Hoshino TH2 cytokines and associated transcription factors as therapeutic targets in asthma Curr Drugs Targets Inflamm Allergy 4 2005 267 270 (Pubitemid 40873109)
43. T.C. Fang, Y. Yashiro-Ohtani, C. Del Bianco, D.M. Knoblock, S.C. Blacklow, and W.S. Pear Notch directly regulates Gata3 expression during T helper 2 cell differentiation Immunity 27 2007 100 110 (Pubitemid 47096803)
44. J.A. Rankin, D.E. Picarello, G.P. Geba, U.A. Temann, B. Prasad, and B. DiCosmo Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity Proc Natl Acad Sci USA 93 1996 7821 7825 (Pubitemid 26277122)
45. G. Brusselle, J. Kips, G. Joos, H. Bluethmann, and R. Pauwels Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice Am J Respir Cell Mol Biol 12 1995 254 259
46. W.R. Henderson, E.Y. Chi, and C.R. Maliszewski Soluble IL-4 receptor inhibits airway inflammation following antigen challenge in a mouse model of asthma J Immunol 164 2000 1086 1095 (Pubitemid 30043738)
47. S.H. Gavett, D.J. O'Hearn, C.L. Karp, E.A. Patel, B.H. Schofield, and F.D. Finkelman Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice Am J Physiol 272 1997 L253 L261
48. J.C. Kips, K.G. Tournoy, and R.A. Pauwels New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5 Eur Respir J 17 2001 499 506 (Pubitemid 32600622)
49. C.K. Oh, G.P. Geba, and N. Molfino Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma Eur Respir Rev 19 2010 46 54
50. P. Harris, D. Lindell, N. Fitch, and R. Gundel The IL-4 receptor antagonist (BAY-16-9996) reverses airway hyperresponsiveness in a primate model of asthma Am J Respir Crit Care Med 159 1999 A230
51. A.N. Menzies-Gow, P.T. Flood-Page, D.S. Robinson, and A.B. Kay Effect of inhaled interleukin-5 on eosinophil progenitors in the bronchi and bone marrow of asthmatic and non-asthmatic volunteers Clin Exp Allergy 37 2007 1023 1032 (Pubitemid 46955515)
52. MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor. http://pressroom.medimmune.com/ pressreleases/2008/12/04/medimmune-advances-asthma-program-with-start-of-phase- 2-clinical-trial-for-antibody-targeting-il-5-receptor/.
53. Z. Allakhverdi, M. Allam, and P.M. Renzi Inhibition of antigen-induced eosinophilia and airway hyperresponsiveness by antisense oligonucleotides directed against the common beta chain of IL-3, IL-5, GM-CSF receptors in a rat model of allergic asthma Am J Respir Crit Care Med 165 2002 1015 1021 (Pubitemid 34774674)
54. Z. Allakhverdi, M. Allam, A. Guimond, N. Ferrari, K. Zemzoumi, and R. Séguin Multitargeted approach using antisense oligonucleotides for the treatment of asthma Ann N Y Acad Sci 1082 2006 62 73 (Pubitemid 44955451)
55. U.A. Temann, G.P. Geba, J.A. Rankin, and R.A. Flavell Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness J Exp Med 188 1998 1307 1320 (Pubitemid 28478019)
56. P. Soroosh, and T.A. Doherty Th9 and allergic disease Immunology 127 2009 450 458
57. E. Truyen, E. Dilissen, L. Overbergh, L.J. Dupont, J.L. Ceuppens, and D.M. Bullens Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthmatic patients Thorax 61 2006 202 208
58. C.K. Kim, J. Choi, Z. Callaway, G. Volcheck, and H. Kita Increase in airway eosinophilia and a th1 cytokine during the chronic asymptomatic phase of asthma Respir Med 104 2010 1436 1443
59. D.A. Randolph, R. Stephens, C.J. Carruthers, and D.D. Chaplin Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation J Clin Invest 104 1999 1021 1029 (Pubitemid 29536312)
60. D.D. Chaplin Cell cooperation in development of eosinophil-predominant inflammation in airways Immunol Res 26 2002 55 62 (Pubitemid 35177484)
61. I. Iwamoto, H. Nakajima, H. Endo, and S. Yoshida Interferon γ regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells J Exp Med 177 1993 573 576 (Pubitemid 23117112)
62. A.J. Coyle, S. Tsuyuki, C. Bertrand, S. Huang, M. Aguet, and S.S. Alkan Mice lacking the IFN-γ receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile J Immunol 156 1996 2680 2685 (Pubitemid 126660611)
63. M. Koch, M. Witzenrath, C. Reuter, M. Herma, H. Schütte, and N. Suttorp Role of local pulmonary IFN-γ expression in murine allergic airway inflammation Am J Respir Cell Mol Biol 35 2006 211 219 (Pubitemid 44175321)
64. A. Kanda, V. Driss, N. Hornez, M. Abdallah, T. Roumier, and G. Abboud Eosinophil-derived IFN-γ induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes J Allergy Clin Immunol 124 2009 573 582
65. D.H. Broide, M. Lotz, A.J. Cuomo, D.A. Coburn, E.C. Federman, and S.I. Wasserman Cytokines in symptomatic asthma airways J Allergy Clin Immunol 89 1992 958 967
66. C. Walker, J.C. Virchow Jr. , P.L. Bruijnzeel, and K. Blaser T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma J Immunol 146 1991 1829 1835
67. A. Doganci, R. Karwot, J.H. Maxeiner, P. Scholtes, E. Schmitt, and M.F. Neurath IL-2 receptor beta-chain signaling controls immunosuppressive CD4+ T cells in the draining lymph nodes and lung during allergic airway inflammation in vivo J Immunol 181 2008 1917 1926
68. T. Naseer, E.M. Minshall, D.Y. Leung, S. Laberge, P. Ernst, and R.J. Martin Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy Am J Respir Crit Care Med 155 1997 845 851 (Pubitemid 27133392)
69. S.H. Gavett, D.J. O'Hearn, X. Li, S.K. Huang, F.D. Finkelman, and M. Wills-Karp Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice J Exp Med 182 1995 1527 1536
70. G.G. Bruselle, J.C. Kips, R.A. Peleman, G.F. Joos, R.R. Devos, and J.H. Tavernier Role of IFN-gamma in the inhibition of the allergic airway inflammation caused by IL-12 Am J Respir Cell Mol Biol 17 1997 767 771 (Pubitemid 127348668)
71. L. Borish, A. Aarons, J. Rumbyrt, P. Cvietusa, J. Negri, and S. Wenzel Interleukin-10 regulation in normal subjects and patients with asthma J Allergy Clin Immunol 97 1996 1288 1296 (Pubitemid 26192279)
72. M.R. van Scott, J.P. Justice, J.F. Bradfield, E. Enright, A. Sigounas, and S. Sur IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice Am J Physiol 278 2000 L667 L674
73. M.R. Stämpfli, M. Cwiartka, B.U. Gajewska, D. Alvarez, S.A. Ritz, and M.D. Inman Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice Am J Respir Cell Mol Biol 21 1999 586 596 (Pubitemid 129586594)
74. K. Presser, D. Schwinge, M. Wegmann, S. Huber, S. Schmitt, and A. Quaas Coexpression of TGF-β1 and IL-10 enables regulatory T cells to completely suppress airway hyperreactivity J Immunol 181 2008 7751 7758
75. P. Miossec, T. Korn, and V.K. Kuchroo Interleukin-17 and type 17 helper T cells New Engl J Med 361 2009 888 898
76. J. Pne, S. Chevalier, L. Preisser, E. Vénéreau, M.H. Guillex, and S. Ghannam Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes J Immunol 180 2008 7423 7430
77. S. Schnyder-Candrian, D. Togbe, I. Couillin, I. Mercier, F. Brombacher, and V. Quesniaux Interleukin-17 is a negative regulator of established allergic asthma J Exp Med 203 2006 2715 2725 (Pubitemid 44833347)
78. S.H. Cho, L.A. Stanciu, S.T. Holgate, and S.L. Johnston Increased interleukin 4, interleukin 5, and interferon-γ in airway CD4+ and CD8+ T cells in atopic asthma Am J Respir Crit Care Med 171 2005 224 230
79. R.J. Betts, and D.M. Kemeny CD8+ T cells in asthma: friend or foe? Pharmacol Ther 121 2009 123 131
80. A.J. Coyle, F. Erard, C. Bertrand, S. Walti, H. Pircher, and G. Le Gros Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia J Exp Med 181 1995 1229 1233
81. S.M. O'Sullivan Asthma death, CD8+ T cells, and viruses Proc Am Thorac Soc 2 2005 162 165 (Pubitemid 41233385)
82. L.J. Smyth, A. Eustace, U. Kolsum, J. Blaikely, and D. Singh Increased airway T regulatory cells in asthmatic subjects Chest 138 2010 905 912
83. D. Hartl, B. Koller, A.T. Melhorn, D. Reinhardt, T. Nicolai, and D.J. Schendel Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma J Allergy Clin Immunol 119 2007 1258 1266 (Pubitemid 46654192)
84. T.H. Schreiber, D. Wolf, M.S. Tsai, J. Chirinos, V.V. Deyev, and L. Gonzalez Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation J Clin Invest 120 2010 3629 3640
85. M.H. Nyirenda, K. O'Brien, L. Sanvito, C.S. Constantinescu, and B. Gran Modulation of regulatory T cells in health and disease: role of toll-like receptors Inflamm Allergy Drug Targets 8 2009 124 129
86. G. Suntharalingam, M.R. Perry, S. Ward, S.J. Brett, A. Castelo-Cortes, and M.D. Brunner Cytokine storm in a Phase 1 trial of the anti-CD28 monoclonal antibody TGN1412 New Engl J Med 355 2006 1018 1028 (Pubitemid 44343545)
87. R. Boyton The role of natural killer T cells in lung inflammation J Pathol 214 2008 276 282 (Pubitemid 351160164)
88. P. Vijayanand, G. Seumois, C. Pickard, R.M. Powell, G. Angco, and D. Sammut Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease N Engl J Med 356 2007 1401 1422
89. C. Reynolds, J. Barkans, P. Clark, H. Kariyawasam, D. Altmann, and B. Kay Natural killer T cells in bronchial biopsies from human allergen challenge model of allergic asthma J Allergy Clin Immunol 124 2009 860 862
90. F. Spinozzi, E. Agea, O. Bistoni, N. Forenza, A. Monaco, and G. Bassotti Increased allergen-specific, steroid-sensitive gamma delta T cells in bronchoalveolar lavage fluid from patients with asthma Ann Intern Med 124 1996 223 227 (Pubitemid 26026006)
91. M. Lahn, A. Kanehiro, K. Takeda, A. Joetham, J. Schwarze, and G. Kohler Negative regulation of airway responsiveness that is dependent on gammadelta T cells and independent of alphabeta T cells Nat Med 5 1999 1150 1156 (Pubitemid 29474419)
92. S. Isogai, A. Athiviraham, R.S. Fraser, R. Taha, Q. Hamid, and J.G. Martin Interferon-gamma-dependent inhibition of late allergic airway responses and eosinophilia by CD8+ gammadelta T cells Immunology 122 2007 230 238 (Pubitemid 47389951)
93. A. Nambu, and S. Nakae IL-1 and allergy Allergol Int 59 2010 125 135
94. D.J. Amrol, D.D. Hagaman, J.R. Sheller, and J.J. Murray Soluble CD23 and interleukin-1 receptor antagonist in human asthmatics following antigen challenge J Asthma 42 2005 73 76 (Pubitemid 40365733)
95. J.-H. Lee, L.-C. Wang, H.-H. Yu, Y.-T. Lin, Y.-H. Yang, and B.-L. Chiang Type I IL-1 receptor (IL-1RI) as a potential new therapeutic target for bronchial asthma Mediators Inflamm 2010 2010 567351 10.1155/2010/567351
96. O. Dienz, and M. Rincon The effects of IL-6 on CD4 T cell responses Clin Immunol 130 2009 27 33
97. A. Doganci, K. Sauer, R. Karwot, and S. Finotto Pathological role of IL-6 in the experimental allergic bronchial asthma in mice Clin Rev Allergy Immunol 28 2005 257 270
98. W.A. Neveu, J.L. Allard, D.M. Raymond, L.M. Bourassa, S.M. Burns, and J.Y. Bunn Elevation of Il-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function Respir Res 11 2010 28
99. A. Doganci, T. Eigenbrod, N. Krug, G.T. De Sanctis, M. Hausding, and V.J. Erpenbeck The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo J Clin Invest 115 2005 313 325 (Pubitemid 40385473)
100. V.M. Keatings, P.D. Collins, D.M. Scott, and P.J. Barnes Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma Am J Respir Crit Care Med 153 1996 530 534
101. P.H. Howarth, K.S. Babu, H.S. Arshad, L. Lau, M. Buckley, and W. McConnell Tumour necrosis factor (TNFa) as a novel therapeutic target in symptomatic corticosteroid dependent asthma Thorax 60 2005 1012 1018 (Pubitemid 41705469)
102. P.S. Thomas, D.H. Yates, and P.J. Barnes Tumor necrosis factor-α increases airway responsiveness and sputum neutrophilia in normal human subjects Am J Respir Crit Care Med 152 1995 76 80
103. S. Hutchison, B.S. Choo-Kang, R.V. Bundick, A.J. Leishman, J.M. Brewer, and I.B. McInnes Tumour necrosis factor-alpha blockade suppresses murine allergic airways inflammation Clin Exp Immunol 151 2008 114 122 (Pubitemid 350230978)
104. A.J. Wardlaw Eosinophil trafficking in asthma Clin Med 1 2001 214 218 (Pubitemid 33611619)
105. M. Wegmann, R. Göggel, S. Sel, S. Sel, K.J. Erb, and F. Kalkbrenner Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma Am J Respir Cell Mol Biol 36 2007 61 67 (Pubitemid 46067708)
106. M. Komai, H. Tanaka, K. Nagao, M. Ishizaki, D. Kajiwara, and T. Miura A novel CC-chemokine receptor 3 antagonist, Ki19003, inhibits airway eosinophilia and subepithelial/peribronchial fibrosis induced by repeated antigen challenge in mice J Pharmacol Sci 112 2010 203 213
107. P. Vijayanand, K. Durkin, G. Hartmann, J. Morjaria, G. Seumois, and K.J. Staples Chemokine receptor 4 plays a key role in T cell recruitment into the airways of asthmatic patients J Immunol 184 2010 4568 4574
108. F. Perros, H.C. Hoogsteden, A.J. Coyle, B.N. Lambrecht, and H. Hammad Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation Allergy 64 2009 995 1002
109. T. Sato, M. Komai, M. Iwase, K. Kobayashi, H. Tahara, and E. Oshima Inhibitory effect of the new orally active CCR4 antagonist K327 on CCR4+CD4+ T cell migration into the lung of mice with ovalbumin-induced lung allergic inflammation Pharmacology 84 2009 171 182
110. T.S. Hallstrand, and W.R. Henderson Jr. An update on the role of leukotrienes in asthma Curr Opin Allergy Clin Immunol 10 2010 60 66
111. S.A. Islam, S.Y. Thomas, C. Hess, B.D. Medoff, T.K. Means, and C. Brander The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans Blood 107 2006 444 453 (Pubitemid 43076363)
112. N. Miyahara, K. Takeda, S. Miyahara, C. Taube, A. Joetham, and T. Koya Leukotriene B4 receptor-1 is essential for allergen-mediated recruitment of CD8+ T cells and airway hyperresponsiveness J Immunol 174 2005 4979 4984
113. K. Waseda, N. Miyahara, A. Kanehiro, G. Ikeda, H. Koga, and Y. Fuchimoto Blocking the leukotriene B4 receptor 1 inhibits late phase airway responses in established disease Am J Respir Cell Mol Biol March 2011 [Epub ahead of print]
114. S.R. Barthel, M.W. Johansson, D.M. McNamee, and D.F. Mosher Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma J Leukoc Biol 83 2008 1 12
115. N.H. ten Hacken, D.S. Postma, F. Bosma, G. Drok, B. Rutgers, and J. Kraan Vascular adhesion molecules in nocturnal asthma: a possible role for VCAM-1 in ongoing airway wall inflammation Clin Exp Allergy 28 1998 1518 1525 (Pubitemid 29003327)
116. M.W. Johansson, E.A. Kelly, W.W. Busse, N.N. Jarjour, and D.F. Mosher Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge J Immunol 180 2008 7622 7635
117. D.J. Goetz, D.M. Greif, H. Ding, R.T. Camphausen, S. Howes, and K.M. Comess Isolated P-selectin glycoprotein ligand-1 dynamic adhesion to P- and E-selectin J Cell Biol 137 1997 509 519
118. P. Vanderslice, R.J. Biediger, D.G. Woodside, K.L. Berens, G.W. Holland, and R.A. Dixon Development of cell adhesion molecule antagonists as therapeutics for asthma and COPD Pulm Pharmacol Ther 17 2004 1 10 (Pubitemid 37468403)
119. E.R. Walsh, and A. August Eosinophils and allergic airway disease: there is more to the story Trends Immunol 31 2010 39 44
120. W.W. Busse The relationship of airway hyperresponsiveness and airway inflammation: airway hyperresponsiveness in asthma: its measurement and clinical significance Chest 138 Suppl. 2 2010 4S 10S
121. R.H. Gundel, L.G. Letts, and G.J. Gleich Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates J Clin Invest 87 1991 1470 1473
122. R.H. Gundel, C.D. Wegner, and L.G. Letts The onset and recovery from airway hyperresponsiveness: relationship with inflammatory cell infiltrates and release of cytotoxic granule proteins Clin Exp Allergy 22 1992 303 308
123. C.A. Rizzo, R. Yang, S. Greenfeder, R.W. Egan, R.A. Pauwels, and J.A. Hey The IL-5 receptor on human bronchus selectively primes for hyperresponsiveness J Allergy Clin Immunol 109 2002 404 409 (Pubitemid 34234188)
124. C. Perkins, N. Yanase, G. Smulian, L. Gildea, T. Orekov, and C. Potter Selective stimulation of IL-4 receptor on smooth muscle induces airway hyperresponsiveness in mice J Exp Med 208 2011 853 867
125. A. Kanda, V. Driss, N. Nornez, M. Abdallah, T. Roumier, and G. Abboud Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes J Allergy Clin Immunol 124 2009 573 582
126. G. Woszczek, L.Y. Chen, S. Nagineni, S. Alsaaty, A. Harry, and C. Logun IFN-gamma induces cysteinyl leukotriene receptor 2 expression and enhances the responsiveness of human endothelial cells to cysteinyl leukotrienes J Immunol 178 2007 5262 5270 (Pubitemid 46595311)
127. J. Zhu, Y.S. Qiu, D.J. Figueroa, V. Bandi, H. Galczenski, and K. Hamada Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa Am J Respir Cell Mol Biol 33 2005 531 540 (Pubitemid 41753128)
128. D. Ihaku, L. Cameron, M. Suzuki, S. Molet, J. Martin, and Q. Hamid Montelukast, a leukotriene receptor antagonist, inhibits late airway response to antigen, airway eosinophilia, and IL-5-expressing cells in Brown Norway rats J Allergy Clin Immunol 104 1999 1147 1154 (Pubitemid 30004972)
129. J.F. Blain, and P. Sirois Involvement of LTD(4) in allergic pulmonary inflammation in mice: modulation by cysLT(1) antagonist MK-571 Prostaglandins Leukot Essent Fatty Acids 62 2000 361 368 (Pubitemid 30623881)
130. S.-Y. Eum, K. Maghni, Q. Hamid, H. Campbell, D.H. Eidelman, and J.G. Martin Involvement of cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse Am J Respir Cell Mol Biol 28 2003 25 32 (Pubitemid 36017047)
131. R. Leigh, D. Vethanayagam, M. Yoshida, R.M. Watson, T. Rerecich, and M.D. Inman Effects of montelukast and budesonide on airway responses and airway inflammation in asthma Am J Respir Crit Care Med 166 2002 1212 1217 (Pubitemid 35222598)
132. K.F. Austen, A. Maekawa, Y. Kanaoka, and J.A. Boyce The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications J Allergy Clin Immunol 124 2009 406 414
133. T.H. Lee, G. Woszczek, and S.P. Farooque Leukotriene E4: perspective on the forgotten mediator J Allergy Clin Immunol 124 2009 417 421
134. T.H. Lee, K.F. Austen, E.J. Corey, and J.M. Drazen Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors Proc Natl Acad Sci USA 81 1984 4922 4925 (Pubitemid 14066226)
135. S. Paruchuri, H. Tashimo, C. Feng, A. Maekawa, W. Xing, and Y. Jiang Leukotriene E4-induce pulmonary inflammation is mediated by the P2Y12 receptor J Exp Med 206 2009 2543 2555
136. A. Sala, G. Folco, and R.C. Murphy Transcellular biosynthesis of eicosanoids Pharmacol Rep 62 2010 503 510
137. M.M. Gueders, G. Paulissen, C. Crahay, F. Quesada-Calvo, J. Hacha, and C. Van Hove Mouse models of asthma: a comparison between C57BL/6 and BALB/c strains regarding bronchial responsiveness, inflammation, and cytokine production Inflamm Res 58 2009 845 854
138. V. De Vooght, J.A. Vaniorbeek, K. Luyts, S. Haenen, B. Nemery, and P.H. Hoet Choice of mouse strain influences the outcome in a mouse model of chemical-induced asthma PLoS One 5 9 2010 e12581
139. S.N. Kelada, M.S. Wilson, U. Tavarez, K. Kubalanza, B. Borate, and G. Whitehead Strain-dependent genomic factors affect allergen-induced airway hyper-responsiveness in mice Am J Respir Cell Mol Biol March 2011 [Epub ahead of print]
140. D. Togbe, S. Schnyder-Candrian, B. Schnyder, E. Doz, N. Noulin, and L. Janot Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury Int J Exp Pathol 88 2007 387 391 (Pubitemid 350173704)
141. B.J. O'Connor, S.D. Crowther, J.F. Costello, and J. Morley Selective airway responsiveness in asthma Trends Pharmacol Sci 20 1999 9 11 (Pubitemid 29304519)
142. J.D. Brannan, M. Gulliksson, S.D. Anderson, N. Chew, and M. Kumlin Evidence of mast cell activation and leukotriene release after mannitol inhalation Eur Respir J 22 2003 491 496 (Pubitemid 37098931)
143. S.D. Anderson, J.D. Brannan, C.P. Perry, C. Caillaud, and J.P. Seale Sodium cromoglycate alone and in combination with montelukast on the airway response to mannitol in asthmatic subjects J Asthma 47 2010 429 433
144. P.M. O'Byrne Allergen-induced airway inflammation and its therapeutic intervention Allergy Asthma Immunol Res 1 2009 3 9
145. S. Fernandez-Rodriguez, K.J. Broadley, W.R. Ford, and E.J. Kidd Increased muscarinic receptor activity of airway smooth muscle isolated from a mouse model of allergic asthma Pulm Pharmacol Ther 23 2010 300 307
146. K. Hoshiko, and J. Morley Allergic bronchospasm and airway hyperreactivity in the guinea-pig Jpn J Pharmacol 63 1993 151 157 (Pubitemid 23337277)
147. J. Morley, I.D. Chapman, K. Hoshiko, and L. Mazzoni Acute airway hyperreactivity in the guinea-pig Eur Respir Rev 5 1995 202 210
148. S. Siddiqui, V. Mistry, C. Doe, S. Stinson, M. Foster, and C. Brightling Airway wall expression of OX40/OX40L and interleukin-4 in asthma Chest 137 2010 798 804
149. A.A. Long Monclonal antibodies and other biologic agents in the treatment of asthma MAbs 1 2009 237 246
150. L.C. Borish, H.S. Nelson, M.J. Lanz, L. Claussen, J.B. Whitmore, and J.M. Agosti Interleukin-4 receptor in moderate atopic asthma. A Phase I/II randomized, placebo-controlled trial Am J Respir Crit Care Med 160 1999 1816 1823 (Pubitemid 30004681)
151. L.C. Borish, H.C. Nelson, J. Corren, G. Bensch, W.W. Busse, and J.B. Whitmore Efficacy of soluble IL-4 receptor for the treatment of adults with asthma J Allergy Clin Immunol 107 2001 963 970 (Pubitemid 32523334)
152. I.M. Adcock, G. Caramori, and K.F. Chung New targets for drug development in asthma Lancet 372 2008 1073 1087
153. J.C. Kips, B.J. O'Connor, S.J. Langley, A. Woodcock, H.A.M. Kerstjens, and D.S. Postma Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma. A pilot study Am J Respir Crit Care Med 167 2003 1655 1659 (Pubitemid 36760679)
154. M. Castro, S. Mathur, F. Hargreave, F. Xie, J. Young, and H.J. Wilkins Reslizumab in the treatment of poorly controlled asthma in patients with eosinophilic airway inflammation Abstract at ACAAI meeting, November 2010 [Poster 64]
155. M.J. Leckie, A. ten Brinke, J. Khan, Z. Diamant, B.J. O'Connor, and C.M. Walls Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response Lancet 356 2000 2144 2148
156. P.T. Flood-Page, A.N. Menzies-Gow, A.B. Kay, and D.S. Robinson Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway Am J Respir Crit Care Med 167 2003 199 204 (Pubitemid 36076080)
157. P.T. Flood-Page, C. Swenson, I. Faiferman, J. Matthews, M. Williams, and L. Brannick A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma Am J Respir Crit Care Med 176 2007 1062 1071 (Pubitemid 350223751)
158. P. Haldar, C.E. Brightling, B. Hargadon, S. Gupta, W. Monteiro, and A. Sousa Mepolizumab and exacerbations of refractory eosinophilic asthma New Engl J Med 360 2009 973 984
159. P. Nair, M.M.M. Pizzichini, M. Kjarsgaard, M.D. Inman, A. Efthimiadis, and E. Pizzichini Mepolizumab for prednisone-dependent asthma with sputum eosinophilia New Engl J Med 360 2009 985 993
160. S.E. Wenzel Eosinophils in asthma - closing the loop or opening the door? New Engl J Med 360 2009 1026 1028
161. R. Kolbeck, A. Kozhich, M. Koike, L. Peng, C.K. Andersson, and M.M. Damschroder MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function J Allergy Clin Immunol 125 2010 1344 1353
162. J. Corren, W. Busse, E.O. Meltzer, L. Mansfield, G. Bensch, and J. Fahrenholz A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma Am J Respir Crit Care Med 181 2010 788 796
163. Pipeline Watch, March 18th 2011. www.scripintelligence.com/multimedia/ archive/00143/Scrip-3539-Pipeline-143239a.pdf.
164. S.E. Wenzel, D. Wilbraham, R. Fuller, E.B. Getz, and M. Longphre Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies Lancet 370 2007 1422 1431 (Pubitemid 47576168)
165. Phase 2b Clinical Trial Results Show Aerovance's Aerovant™ is Effective in Patients with Eosinophilic Asthma. Statistically Significant Results Support Novel Inhaled IL-4/IL-13 Inhibitor's Continued Clinical Development. Press release June 8, 2010. http://www.aerovance.com/news/press- releases/Press-Releases/Phase-2b-Clinical-Trial-Results-Show-Aerovances- Aerovant-is-Effective-in-Patients-with-Eosinophilic-Asthma-92/.
166. G.M. Gauvreau, L.P. Boulet, D.W. Cockcroft, J.M. Fitzgerald, C. Carlsten, and B.E. Davis Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma Am J Respir Crit Care Med 183 2011 1007 1014
167. G.M. Gauvreau, R. Pageau, R. Séguin, D. Carballo, J. Gauthier, and H. D'Anjou Dose-response effects of TPI ASM8 in asthmatics after allergen Allergy May 2011 10.1111/j.1398-9995.2011.02638.x
168. S.A. Antoniu MEDI-528, an anti-IL-9 humanized antibody for the treatment of asthma Curr Opin Mol Ther 12 2010 233 239
169. J. Parker, S. Brazinsky, D.S. Miller, A. Nayak, P.E. Korenblat, and S. Sari Randomized, double-blind, placebo-controlled, multicenter phase 2a study to evaluate the effect of a humanized interleukin-9 monoclonal antibody (MEDI-528) on exercise-induced bronchospasm Am J Respir Crit Care Med 181 2010 A5394
170. M. Boguniewicz, L.C. Schneider, H. Milgrom, D. Newell, N. Kelly, and P. Tam Treatment of steroid-dependent asthma with recombinant interferon-gamma Clin Exp Allergy 23 1993 785 790 (Pubitemid 23294875)
171. M. Boguniewicz, R.J. Martin, D. Martin, U. Gibson, A. Celniker, and M. Williams The effects of nebulized recombinant interferon-gamma in asthmatic airways J Allergy Clin Immunol 95 1995 133 135
172. S.A. Bryan, B.J. O'Connor, S. Matti, M.J. Leckie, V. Kanabar, and J. Khan Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response Lancet 356 2000 2149 2153
173. C.S. Park, S.M. Lee, S.W. Chung, S. Uh, H.T. Kim, and Y.H. Kim Interleukin-2 and soluble interleukin-2 receptor in bronchoalveolar lavage fluid from patients with bronchial asthma Chest 106 1994 400 406 (Pubitemid 24252033)
174. W.W. Busse, E. Israel, H.S. Nelson, J.W. Baker, B.L. Charous, and D.Y. Young Daclizumab improves asthma control in patients with moderate to severe persistent asthma. A randomized, controlled trial Am J Respir Crit Care Med 178 2008 1002 1008
175. D.J. Evans, P.J. Barnes, S.M. Spaethe, E.L. van Alstyne, M.I. Mitchell, and B.J. O'Connor Effect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma Thorax 51 1996 1178 1184 (Pubitemid 26413134)
176. Z. Diamant, J. Kuperus, R. Baan, K. Nietzmann, S. Millet, and P. Mendes Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma Clin Exp Allergy 35 2005 1080 1087 (Pubitemid 41603143)
177. A.J. Ravensberg, B. Luijk, P. Westers, P.S. Hiemstra, P.J. Sterk, and R.W. Lammers The effect of a single inhaled dose of a VLA-4 antagonist in allergen-induced airway responses and airway inflammation in patients with asthma Allergy 61 2006 1097 1103 (Pubitemid 44175217)
178. V. Norris, L. Choong, D. Tran, Z. Corden, M. Boyce, and H. Arshad Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma J Allergy Clin Immunol 116 2005 761 767 (Pubitemid 41400538)
179. G.M. Gauvreau, A.B. Becker, L.P. Boulet, J. Chakir, R.B. Fick, and W.L. Greene The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma J Allergy Clin Immunol 112 2003 331 338 (Pubitemid 36981373)
180. P.C. Avila, H.A. Boushey, H. Wong, H. Grundland, J. Liu, and J.V. Fahy Effect of a single dose of the selectin inhibitor TBC1269 on early and late asthmatic responses Clin Exp Allergy 34 2004 77 84 (Pubitemid 38183684)
181. K.M. Beeh, J. Beier, M. Meyer, R. Buhl, R. Zahlten, and G. Wolff Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial Pulm Pharmacol Ther 19 2006 233 241
182. F.N. Rouhani, C.A. Meitin, M. Kaler, D. Miskinis-Hilligoss, M. Stylianou, and S.J. Levine Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation Respir Med 99 2005 1175 1182 (Pubitemid 41102656)
183. M.A. Berry, B. Hargadon, M. Shelley, D. Parker, D.E. Shaw, and R.H. Green Evidence of a role of tumor necrosis factor alpha in refractory asthma New Engl J Med 354 2006 697 708 (Pubitemid 43247140)
184. J.B. Morjaria, A.J. Chauhan, K.S. Babu, R. Polosa, D.E. Davies, and S.T. Holgate The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomized, placebo controlled trial Thorax 63 2008 584 591 (Pubitemid 351969250)
185. E.M. Erin, B.R. Leaker, G.C. Nicholson, A.J. Tan, L.M. Green, and H. Neighbour The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma Am J Respir Crit Care Med 174 2006 753 762 (Pubitemid 44511656)
186. S.E. Wenzel, P.J. Barnes, E.R. Bleecker, J. Bousquet, W. Busse, and S.-E. Dahlé A randomized, double-blind, placebo-controlled study of tumor necrosis factor-a blockade in severe persistent asthma Am J Respir Crit Care Med 179 2009 549 558
187. L.J. Rosenwasser Biologic activities of IL-1 and its role in human disease J Allergy Clin Immunol 102 1998 344 350 (Pubitemid 28471489)
188. H.R.H.R. Davies, L.L.G. Olson, and P.G. Gibson Methotrexate as a steroid sparing agent for asthma in adults Cochrane Database Syst Rev 3 1998 CD00391
189. D.J. Evans, P. Cullinan, and D.M. Geddes Cyclosporin as an oral corticosteroid sparing agent in stable asthma Cochrane Database Syst Rev 2 2001 CD002993
190. T. Dean, A. Dewey, A. Bara, T.J. Lasserson, and E.H. Walters Azathioprine as an oral corticosteroid sparing agent for asthma Cochrane Database Syst Rev 1 2004 CD003270
191. D.J. Evans, P. Cullinan, and D.M. Geddes Gold as an oral corticosteroid sparing agent in stable asthma Cochrane Database Syst Rev 2 2001 CD002985
192. L.M. Salmun, I. Barlan, H.M. Wolf, M. Eibl, F.J. Twarog, and R.S. Geha Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial J Allergy Clin Immunol 103 1999 810 815 (Pubitemid 29297583)
193. O.M. Kon, B.S. Sihra, C.H. Compton, T.B. Leonard, A.B. Kay, and N.C. Barnes Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma Lancet 352 1998 1109 1113 (Pubitemid 28448517)
194. O.M. Kon, B.S. Sihra, L.C. Loh, J. Barkans, C.H. Compton, and N.C. Barnes The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma Eur Respir J 18 2001 45 52 (Pubitemid 32717430)
195. L. Borish IL-4 and IL-13 dual antagonism: a promising approach to the dilemma of generating effective asthma biotherapeutics Am J Respir Crit Care Med 181 2010 769 770
196. Popper K. The logic of scientific discovery. First published in 1935 by Verlag von Julius Springer, Vienna, Austria. Published as a Routledge Classic in 2002, by Routledge, London and NY.
197. R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D. Parker, and P. Bradding Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 360 2002 1715 1721 (Pubitemid 35447900)
198. L. Jayaram, M.M. Pizzichini, R.J. Cook, L.P. Boulet, C. Lemire, and E. Pizzichini Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Eur Respir J 27 2006 483 494 (Pubitemid 43372521)
199. P.G. Woodruff, B. Modrek, D.F. Choy, G. Jia, A.R. Abbas, and A. Ellwager T-helper Type 2-driven inflammation defines major subphenotypes of asthma Am J Respir Crit Care Med 180 2009 388 395
200. J.R. Murdoch, and C.M. Lloyd Chronic inflammation and asthma Mutat Res 690 2010 24 39
201. H.A. Rabb, R. Olivenstein, T.B. Issekutz, P.M. Renzi, and J.G. Martin The role of the leukocyte adhesion molecules VLA-4, LFA-1, and Mac-1 in allergic airway responses in the rat Am J Respir Crit Care Med 149 1994 1186 1191 (Pubitemid 24147059)